A study done by researchers from the University of Edinburgh shows an increase in risk to the heart attack with jobs involving high temperatures such as firefighting. Researchers conducted studies among 19 healthy and non-smoking individuals from the Scottish Fire and Rescue Service. The participants were subjected to extremely high temperatures and monitored them with heart monitors. The researchers observed following health conditions in the participants after exposing them to extremely high temperatures.
Researchers think a loss of fluid and body response to inflammation caused thickening of the blood and caused blood clotting. Researchers say the risk to the heart attack with extremely high temperatures will be reduced if the people stay well hydrated. This study was funded by the British Heart Foundation (BHF). Lead author of the study was Prof Nick Mills, a research fellow at the University of Edinburgh and the study findings were published in the Circulation.
Researchers from the University Of California have developed a new drug in the form of a pill which can reverse type 2 diabetes (T2D) condition by inhibition of low molecular weight protein tyrosine phosphatase (LMPTP) enzyme. The new drug restores insulin sensitivity of the cells of the diabetes patient. They conducted successful studies and reversed type ii diabetes (T2D) condition in obese mice models having high blood sugar levels by daily administering the newly developed drug.
The researchers say the presence of LMPTP activity reduces insulin sensitivity of the cell to insulin. As insulin weakens, the human body can't maintain increased blood sugar levels in the body and causes the development of type 2 diabetes. The newly developed drug reduces LMPTP enzyme activity and restores cell's functionality and insulin sensitivity. The mice models under the trials did not show any adverse side effects. The researchers say more studies are required with the drug to prove the safety of the drug to conduct human trials. Researchers are very optimistic that their new drug will become a new therapeutic strategy for the reversal of type 2 diabetes condition. Lead author of the study was Stephanie M Stanford and the study findings were published in the journal Nature.
A study done by researchers from the University of Glasgow shows risk reduction to the development of cardiovascular disease, premature death from any cause and cancer if the commuters swap their bus or car pass for a cycle. Walking benefits to individual's health but not to the extent with cycling. Researchers concluded their findings after conducting studies with 264,337 participants over a period of five years.
The study findings were published in the British Medical Journal (BMJ).
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.